Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001539497-22-001683
Filing Date
2022-10-20
Accepted
2022-10-20 11:11:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G n3315_x1-sc13g.htm SC 13G 49131
  Complete submission text file 0001539497-22-001683.txt   50327
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92867 | Film No.: 221320392
SIC: 2834 Pharmaceutical Preparations

Mailing Address 411 RIDGE ROAD ORANGE, CONNECTICUT 06477 CT 06477
Business Address
Khire Uday (Filed by) CIK: 0001951240 (see all company filings)

Type: SC 13G